PRF membrane

PreclinicalBiologic

AAl-Mustansiriyah University

PRF membrane is one of 3 biologic programs targeting Dental Implant. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Dental ImplantNot yet recruiting

Dental ImplantPreclinical

Not yet recruiting

Competition

Competitive Landscape

3 competitors in Dental Implant

#DrugCompanyPhaseTrials

Vit D

PPost Graduate Institute of Medical Education and Research, Chandigarh

Preclinical

2 2

Medications

YYale University

Preclinical

1 3

PRF membrane

AAl-Mustansiriyah University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Dental Implant1 trial

Influence of Human Platelet Derivatives on Dental Implant

Not yet recruiting·—·N/A·NCT06044246·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for PRF membrane. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — PRF membrane compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for PRF membrane. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Al-Mustansiriyah University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: AAl-Mustansiriyah University

PRF membrane

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Dental Implant1 trial

References

Drug Info

Quick Facts

Related News